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Mutational escape from CD8
 
 
 
 T cell immunity: 
HCV evolution, from chimpanzees to man
 
David G. Bowen and Christopher M. Walker
 
The mechanisms by which the hepatitis C virus (HCV) establishes persistence 
are not yet fully understood. Previous chimpanzee and now human studies 
suggest that mutations within MHC class I–restricted HCV epitopes might 
contribute to viral escape from cytotoxic T lymphocyte (CTL) responses. 
However, there are several outstanding questions regarding the role of escape 
mutations in viral persistence and their fate in the absence of immune 
selection pressure.
 
The hepatitis C virus is a small positive-
stranded RNA virus within the 
 
Fla-
viviridae
 
 family that persists in 
 
 
 
70% of
infected individuals, considerably in-
creasing their risk of developing cir-
rhosis and hepatocellular carcinoma.
With an estimated 170 million infected
individuals worldwide, HCV presents a
major global health challenge (1). Studies
of chimpanzees, the only nonhuman
HCV host, have indicated that escape
mutations in MHC class I–restricted
epitopes may play a role in evasion of
the antiviral CTL response (2, 3). In
this issue, three reports demonstrate
that CTL escape mutations also occur
in human HCV infection (4–6) and re-
inforce the general relevance of this
immune evasion mechanism to persis-
tence of RNA viruses in humans.
 
Escape mutations in RNA viruses: 
precedents for HCV infection
 
The majority of RNA viruses produce
RNA polymerases that lack proofreading
activity, and thus encode viral genomes
containing random base mutations. In
the presence of immune selection pres-
sure exerted by CTLs against wild-type
virus, this genomic diversity could facili-
tate  preferential expansion of mutant
progeny encoding altered epitopes that
evade recognition by effector T cells.
The principle of “escape mutations” in
MHC class I–restricted epitopes was
first demonstrated in the model of mu-
rine lymphocytic choriomeningitis viral
infection (7). However, this finding
remained controversial, as escape was
forced by the presence of relatively
high affinity T cell receptor (TCR)
transgenic T cells, and resultant muta-
tions did not enable immune evasion
from a broader epitope-specific re-
sponse by nontransgenic CTLs. The
relevance of this mechanism was ulti-
mately established in studies of HIV
and simian immunodeficiency virus
(SIV) infections, where immune selec-
tion pressure by CD8
 
 
 
 T cells results in
development of escape mutations (8,
9), particularly during the acute phase
of infection (10, 11). The importance
of escape mutations in immune evasion
by these viruses has been confirmed in
studies demonstrating that mutations in
immunodominant epitopes are associ-
ated with progression to AIDS (12),
with escape and subsequent disease
progression after transfer of an autolo-
gous CTL clone (13), and with escape
from partial control afforded by prior
vaccination (14).
 
CTL escape in the chimpanzee model of 
HCV infection
 
Virus-specific CD8
 
 
 
 T cells are unques-
tionably important in the outcome of
HCV infection because the onset of this
response is temporally correlated with
control of acute phase viremia, and anti-
body-mediated depletion of the CD8
 
 
 
 T
cell subset prolongs viral replication in
chimpanzees (1). HCV replication is di-
rected by the error-prone RNA-depen-
dent RNA polymerase encoded by the
viral 
 
NS5b
 
 gene, which due to its pro-
pensity to introduce mutations into the
viral genome might provide the same se-
lective advantage enjoyed by HIV and
SIV. This mechanism of immune escape
may contribute to the remarkable ability
of HCV to persist in infected individuals.
Initial investigations of HCV CTL
mutational escape were performed in
the chimpanzee. The major advantage
of this model is that the sequence of the
infecting inoculum is known, allowing
for accurate analysis of viral evolution.
The initial description of CTL escape
in a single epitope was made relatively
early after the discovery of HCV (2),
but statistical proof that CD8
 
 
 
 T cells
select for HCV escape mutations has
only recently become available. In a
study of three chimpanzees that devel-
oped persistent infection, mutations ab-
rogating CTL function were described
in multiple regions of the viral genome
encoding known epitopes, and were
largely confined to animals expressing
the appropriate restricting MHC class I
allele or a closely related subtype (3).
The ratio of nonsynonymous base sub-
stitution (which changed the amino
acid encoded) to synonymous base sub-
stitution (which left encoded amino acids
unchanged) was higher in regions en-
coding these epitopes than in flanking
sequences, consistent with Darwinian
selection pressure (3). Thus, the limited
data available from this sole animal
model has supported the supposition
that CTL escape mutations occur dur-
ing the course of HCV infection.
 
CTL escape mutation in human 
HCV infection
 
Until very recently, investigation of es-
cape mutation in human HCV infec-
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tions has been limited by practical con-
siderations. As acute hepatitis C is often
cryptic, patients usually do not present
until late in infection. Study of viral
evolution throughout the course of in-
fection has hence proved extremely dif-
ficult. Furthermore, as the genomic
sequence of the infecting inoculum
is rarely known, interpretation of se-
quences obtained from circulating qua-
sispecies in later phases of infection is
problematic. Comparison to published
prototypical HCV sequences partially
circumvents these limitations, and this
approach has provided preliminary indi-
cations that CTL escape mutations oc-
cur during human HCV infection (15).
Proof of the escape hypothesis would
ideally require comparisons between
the evolving viruses and the infectious
inoculum, and not external reference
sequences of published viruses. Much
effort has therefore recently been di-
rected to the surveillance of popula-
tions at high risk of HCV infection, in-
cluding intravenous drug users, health
care workers suffering needle stick in-
juries, and patients undergoing medical
procedures. This allows prospective
monitoring of HCV evolution, analysis
that has to date been unavailable. In
addition, cohorts of individuals in-
fected by a single source of HCV of
known sequence have also been stud-
ied. Such analyses allow definitive as-
sessment of changes within the viral
genome, which are critical to deter-
mining the role of immune selection
pressure in viral evolution. Thus, in a
recent publication in the 
 
Journal of Ex-
perimental Medicine
 
, Timm et al. studied
the evolution of an immunodominant
HLA-B*08–restricted NS3 epitope
during acute HCV infection in two
HLA-B*08–positive patients, one in-
fected by a needle stick injury, and the
other by an undetermined route (16).
CTL-mediated responses to this epi-
tope were followed by the develop-
ment of escape mutations in both indi-
viduals (16).
In this issue, three additional stud-
ies complement and extend this ob-
servation (4–6). These manuscripts in
toto constitute a critical mass of evi-
dence for CTL escape mutations in
human HCV infection. Tester et al.
followed two individuals acutely in-
fected from a single source; in the re-
cipient who did not spontaneously re-
solve infection, escape mutation in an
immunodominant epitope was ob-
served (6). Cox et al. analyzed the
evolution of HCV by partial genome
sequencing in eight acutely infected
individuals, defining escape mutations
in multiple CTL epitopes (4). In the
third study, Ray et al. used the unique
approach of comparing the sequences
of viruses from 22 humans with
chronic hepatitis C with the sequence
of the single common virus that initi-
ated these infections 
 
 
 
20 year earlier
(5). The expression of HLA-B*07,
HLA-B*35, or HLA-B*37 alleles
were found to be linked to the pres-
ence of mutations in epitopes pre-
sented by these alleles, indicating a
likely role for CTL-mediated pressure
in driving viral evolution (5).
 
Mechanisms of CTL escape
 
Thus, as with other highly mutable
RNA viruses, escape mutations in
MHC class I–restricted epitopes are a
feature of HCV infection and can
diminish CTL responses via several
mechanisms. Most recently it has been
demonstrated that amino acid sub-
stitutions within or adjacent to CTL
epitopes can alter proteosomal process-
ing causing epitope destruction before
transport to the endoplasmic reticulum
for MHC binding (16–18). A loss
of epitope phenotype can also occur
when amino acid anchor residues re-
quired for MHC binding are changed
(3, 15). CTL recognition of epitopes
may also be diminished despite ap-
parent conservation of peptide MHC
binding (15), perhaps due to reduced
TCR recognition of the neo-epitope–
MHC complex. Such mutated pep-
tide–MHC complexes may alterna-
tively antagonize responses to the
wild-type epitope (15, 19, 20). These
potential pathways of CTL escape are
summarized in Fig. 1.
It should be noted that CTL escape
has not been observed in all studied
epitopes (3, 5, 21). It is unclear why
HCV-specific CTLs directed against
these unaltered epitopes do not medi-
Figure 1. Mechanisms of CTL escape after mutation in cognate epitopes. (A) Wild-type pep-
tide is correctly processed, binds to MHC, and the resulting complex is recognized by the relevant TCR, 
triggering a CTL response. (B) Mutations in anchoring residues may lead to dissociation of the MHC–
peptide complex. (C) Mutations in the epitope or in flanking regions can alter proteosomal processing, 
leading to destruction of the epitope. (D) Mutated epitopes may bind MHC; however, TCR recognition 
may be reduced or possibly altered, leading to antagonism against responses to the wild-type peptide.
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ate viral clearance in persistently in-
fected individuals, but recent studies
have indicated that their antiviral func-
tions may be impaired in chronic infec-
tion (1).
The factors constraining the emer-
gence of escape mutations are incom-
pletely understood. Even in chronically
HCV-infected individuals, CD8
 
 
 
 T
cell responses can sometimes be di-
rected against a wide range of MHC
class I–restricted epitopes (1). Indeed,
one major criticism of the escape hy-
pothesis has been the assumption that
viral persistence would require almost
simultaneous mutations within multi-
ple epitopes targeted by CTLs. How-
ever, it is possible that the spontaneous
loss of HCV-specific CD4
 
 
 
 T cells that
is consistently observed in subjects who
develop chronic HCV infection (1)
could reduce the effectiveness of CD8
 
 
 
T cells to a point where they select for
viral escape variants, rather than con-
taining infection. Direct support for
this concept was obtained by antibody-
mediated CD4
 
 
 
 T cell depletion of
immune chimpanzees that had resolved
prior HCV infections (22). Rechal-
lenge of animals lacking CD4
 
 
 
 T cells
with the same HCV strain resulted in
viral persistence. Importantly, the fre-
quency and breadth of the memory
CD8
 
 
 
 T cell response was reduced in
this setting, and persistent viruses de-
veloped escape mutations in multiple
MHC class I–restricted epitopes (22).
Consistent with the importance of
CD4
 
 
 
 T cell responses in containing
viral escape, in the study of Tester et
al., mutational escape was associated
with undetectable HCV-specific CD4
 
 
 
T cell responses, whereas in the subject
who resolved infection without muta-
tional escape, broad sustained CD4
 
 
 
 T
cell responses were demonstrated (6).
In addition, a study of HCV-specific
CD8
 
 
 
 T cell responses in HCV-
infected chimpanzees indicated that the
diversity of clonal TCR usage might
also be a factor in the development of
escape mutations (23). In a majority of
cases, escape mutation was associated
with reduced CTL clonal TCR diver-
sity in comparison to epitopes in which
escape mutations were not observed or
those analyzed in chimpanzees that re-
solved infection (23). Similar analysis in
SIV infection has also indicated a link
between diverse clonotypic TCR rep-
ertoires and lack of mutation in the tar-
geted epitope, whereas a more highly
conserved clonotypic TCR repertoire
was associated with viral escape (24).
 
Viral reversion and the meaning of 
consensus sequences
 
It is likely that the emergence of escape
mutations is at least in part governed
by the “fitness cost” imposed on HCV
replication. However, although im-
pairment of propagation may constrain
the emergence of escape mutations in
some structurally critical residues (25),
evidence from studies in HIV and SIV
indicates that compensatory viral muta-
tions can occur, both within epitopes
and in other regions, which allow for
the generation of escape mutations in
highly constrained sites (26–28). Con-
sistent with mutational escape exacting
fitness cost, recent studies of a limited
number of HIV and SIV epitopes have
indicated that reversion of epitopes
to wild-type sequence can occur after
transmission of mutated virus into a
host that does not express the restrict-
ing MHC class I allele (29–31).
Although fitness cost is likely an
important factor shaping HCV evolu-
tion, how individual amino acid substi-
tutions alter replication is not known.
In the acute infection cohort of Cox et
al., sequences from the subjects’ HCV
genomes external to known CTL
epitopes were compared with a corre-
sponding HCV consensus sequence,
and a tendency to mutate toward viral
consensus was found in these regions
(4). Similarly, in the study by Ray et
al., mutation of the HCV genomes to-
ward consensus was noted in regions
outside known CTL epitopes. Addi-
tionally, in HLA-A
 
*
 
01- and B
 
*
 
08-neg-
ative individuals, absence of these al-
leles was associated with evolution
toward consensus within epitopes re-
stricted by these MHC molecules (5).
These results have been interpreted as
indicating that such mutations occur
due to viral reversion to a more fit an-
cestral state (4, 5). Although the avail-
able data supports this model, conclu-
sions are tempered by the absence of
MHC haplotype information for the
donor of the HCV inocula that would
provide additional insight into the se-
lective forces acting on the HCV ge-
nomes before and after transmission.
The concept that consensus se-
quences represent genomes that are the
most antigenic as well as replicatively
fit is being challenged by studies of
HIV evolution and CTL responses.
Recent population-based studies have
indicated that genetic polymorphisms
within certain HIV CTL epitopes are
significantly associated with expression
of the restricting MHC class I alleles
(32), indicating that common HLA al-
leles may leave a “footprint” on this vi-
rus, with loss of epitopes restricted by
highly prevalent HLA class I alleles
(33). Analysis of a limited set of HIV
and SIV CTL escape mutations has in-
dicated that for some mutations main-
tenance of a variant epitope sequence
may be largely confined to subjects ex-
pressing the appropriate restricting
MHC molecule (29–31). On the other
hand, recent data indicates that at least
some HIV CTL escape mutations per-
sist within the viral genome in individ-
uals who do not express the restricting
MHC class I molecule (29, 34). In-
deed, such escape mutations may even
become prevalent enough to enter the
consensus sequence (34), indicating
that for these epitopes, marked fitness
cost is not exacted by viral escape, and
reversion to a more immunogenic an-
cestral state is not automatic upon pas-
sage to a host in which immune se-
lection pressure is absent. Although
similar evidence is not available for
HCV infection, it is interesting to note
that a mutation reported in an HLA-
A*02–restricted epitope in which CTL
escape was mediated by altered pro-
teosomal processing was not observed
at a statistically significant higher fre-
quency among the HLA-A
 
*
 
02–positive
population in comparison to the con-
trol HLA-A
 
*
 
02–negative population
studied (17). It is tempting to speculate
 
20050808  Page 1711  Thursday, May 26, 2005  11:46 PM 
IMMUNE SELECTION PRESSURE AND THE HEPATITIS C VIRUS | Bowen and Walker
 
1712
 
that this phenomenon might be due
to low fitness cost associated with
this particular mutation, thus allow-
ing persistence of the variant sequence
in the absence of immune selection
pressure.
Thus, due to likely interplay be-
tween the opposing forces of immune
selection pressure and viral fitness cost, a
variety of outcomes are possible upon
initial infection with HCV, or after
subsequent transmission of the virus to a
recipient in whom the initial MHC
class I alleles are not expressed. A model
indicating several potential scenarios of
viral evolution is illustrated in Fig. 2.
 
Are CTL escape mutations in HCV 
important for viral persistence?
 
Although it is clear that CTL escape
mutations occur in HCV genomes, the
relevance of this mechanism to viral
persistence is an open question. Muta-
tions usually occur within the first 3–4
months of infection (3, 4), consistent
with the delayed generation of CD8
 
 
 
T cell responses that is an unusual fea-
ture of acute HCV infections (1). Such
observations are compatible with re-
lease from early immune selection pres-
sure as viral escape is established, and
perhaps suggest a role for CTL escape
mutations in the genesis of chronic in-
fection. However, as observed in SIV
infection (9), the rate at which escape
mutations occur during HCV infection
can be highly variable, occurring be-
tween 10 weeks to 2 years postinfec-
tion in chimpanzees (3). It is notable
that once established, escape mutations
in HCV tend to remain fixed within
the circulating quasispecies of an indi-
vidual (3, 15), perhaps driven by per-
sisting CD8
 
 
 
 T cell responses, which
are often concentrated within the liver
(1). The cause of this variability in the
timing of viral escape remains to be de-
termined and may well be governed
largely by the stochastic nature of viral
evolution and a requirement for the
development of compensatory muta-
tions for viruses containing certain es-
cape mutations to remain viable. How-
ever, differences in the kinetics of the
immune response might also be in-
volved in the variable dynamics of vi-
ral evolution. Indeed, future detailed
prospective study of factors such as
the temporal relationship between the
emergence of escape mutations and
breadth and persistence of the HCV-
specific CD4
 
 
 
 T cell response, already
demonstrated as important in disease
resolution and containment of muta-
tional escape (1, 22), might not only
further elucidate a role for these cells in
mutational escape, but also the role of
mutational escape in viral persistence.
 
Concluding remarks
 
Although recent data confirms the gen-
eration of escape mutations in HCV, it
is clear that this field is in its infancy. As
is becoming increasingly apparent from
the immunodeficiency virus literature,
studies comparing circulating viral ge-
nomes to consensus sequences are ex-
tremely difficult to interpret. Further
detailed prospective studies of acute
and evolving HCV infection are re-
quired to delineate the role of escape
mutations in HCV persistence, as well
as to define both the immunological
and virological factors governing viral
evolution. In particular, careful dissec-
tion of these factors will be critical to
the design of any effective CTL-based
vaccine.
Figure 2. Evolution of HCV epitopes after infection. (A) Where a restricting allele is present, 
immune factors such as a sustained CD4  T cell response and diverse clonal CTL TCR repertoire may 
constrain the development of escape mutations; this may be association with viral clearance. (B) Where the 
CD4  T cell response fails and/or the clonal CTL TCR repertoire is narrow, escape mutations may 
emerge. Development of an escape mutation may require additional compensatory mutations. (C) If 
CTL responses are weak or absent, escape mutations may not develop. (D) In the absence of the re-
stricting allele, where there is high fitness cost associated with the presence of an escape mutation, 
reversion to wild-type sequence is likely to occur because of minimal immune selection pressure. 
(E) When there is low associated fitness cost or well developed compensatory mutations in the 
absence of immune selection pressure, the mutated sequence may persist, or perhaps might mutate 
to an equally fit alternative.
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